GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (STU:CP60) » Definitions » Additional Paid-In Capital

The Cooper (STU:CP60) Additional Paid-In Capital : €1,696 Mil(As of Jan. 2024)


View and export this data going back to 1983. Start your Free Trial

What is The Cooper Additional Paid-In Capital?


The Cooper's quarterly additional paid-in capital increased from Jul. 2023 (€1,643 Mil) to Oct. 2023 (€1,736 Mil) but then stayed the same from Oct. 2023 (€1,736 Mil) to Jan. 2024 (€1,696 Mil).

The Cooper's annual additional paid-in capital increased from Oct. 2021 (€1,479 Mil) to Oct. 2022 (€1,792 Mil) but then declined from Oct. 2022 (€1,792 Mil) to Oct. 2023 (€1,736 Mil).


The Cooper Additional Paid-In Capital Historical Data

The historical data trend for The Cooper's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Additional Paid-In Capital Chart

The Cooper Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,459.96 1,399.78 1,478.50 1,791.98 1,736.23

The Cooper Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,651.10 1,642.24 1,642.93 1,736.23 1,695.91

The Cooper Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

The Cooper Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of The Cooper's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper (STU:CP60) Business Description

Traded in Other Exchanges
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (STU:CP60) Headlines

No Headlines